Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-24-000151
Filing Date
2024-01-02
Accepted
2024-01-02 16:50:06
Documents
2
Period of Report
2024-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5434
2 POA DOCUMENT poa.txt EX-24 4033
  Complete submission text file 0001209191-24-000151.txt   11091
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Issuer) CIK: 0001671927 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O IMMUNOCORE LIMITED 92 PARK DRIVE, MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address
Herbst Roy Steven (Reporting) CIK: 0001969520 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39992 | Film No.: 24503206